Brain Tumor Stem Cells as Therapeutic Targets in Models of Glioma

키워드

참고문헌 (99)

1. Jukich PJ, "Trends in incidence of primary brain tumors in the United States, 1985-1994", Neuro Oncol, 3, pp.141~151 (2001)
2. Deorah S, "Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001", Neurosurg Focus, 20, pp.E1~ (2006)
3. Deltour I, "Time trends in brain tumor incidence rates in Denmark, Finland, Norway, and Sweden, 1974-2003", J Natl Cancer Inst, 101, pp.1721~1724 (2009)
4. Pirouzmand F, "The incidence trends of primary brain tumors in Saskatchewan from 1970 to 2001", Can J Neurol Sci, 34, pp.181~186 (2007)
5. Smith MA, "Trends in reported incidence of primary malignant brain tumors in children in the United States", J Natl Cancer Inst, 90, pp.1269~1277 (1998)
6. Hess KR, "Adult glioma incidence trends in the United States, 1977-2000", Cancer, 101, pp.2293~2299 (2004)
7. Schwartzbaum JA, "Epidemiology and molecular pathology of glioma", Nat Clin Pract Neurol, 2, pp.494~503 (2006)
8. Wrensch M, "Epidemiology of primary brain tumors: current concepts and review of the literature", Neuro Oncol, 4, pp.278~299 (2002)
9. Fisher JL, "Epidemiology of brain tumors", Neurol Clin, 25, pp.867~890 (2007)
10. Buckner JC, "Central nervous system tumors", Mayo Clin Proc, 82, pp.1271~1286 (2007)
11. Miller CR, "Glioblastoma", Arch Pathol Lab Med, 131, pp.397~406 (2007)
12. Daumas-Duport C, "Grading of astrocytomas. A simple and reproducible method", Cancer, 62, pp.2152~2165 (1988)
13. Burger PC, "Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsies", Cancer, 63, pp.2014~2023 (1989)
14. Stupp R, "Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma", N Engl J Med, 352, pp.987~996 (2005)
15. Reya T, "Stem cells, cancer, and cancer stem cells", Nature, 414, pp.105~111 (2001)
16. Pardal R, "Applying the principles of stem-cell biology to cancer", Nat Rev Cancer, 3, pp.895~902 (2003)
17. Jordan CT, "Cancer stem cells", N Engl J Med, 355, pp.1253~1261 (2006)
18. Nakano I, "Brain tumor stem cells", Pediatr Res, 59, pp.54R~58 (2006)
19. Dahlstrand J, "Expression of the class VI intermediate filament nestin in human central nervous system tumors", Cancer Res, 52, pp.5334~5341 (1992)
20. Tohyama T, "Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells", Lab Invest, 66, pp.303~313 (1992)
21. Wiese C, "Nestin expression--a property of multi-lineage progenitor cells?", Cell Mol Life Sci, 61, pp.2510~2522 (2004)
22. Sanai N, "Neural stem cells and the origin of gliomas", N Engl J Med, 353, pp.811~822 (2005)
23. Hadjipanayis CG, "Brain cancer propagating cells:biology, genetics and targeted therapies", Trends Mol Med, 15, pp.519~530 (2009)
24. Ignatova TN, "Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro", Glia, 39, pp.193~206 (2002)
25. Hemmati HD, "Cancerous stem cells can arise from pediatric brain tumors", Proc Natl Acad Sci U S A, 100, pp.15178~15183 (2003)
26. Singh SK, "Identification of a cancer stem cell in human brain tumors", Cancer Res, 63, pp.5821~5828 (2003)
27. Reynolds BA, "Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system", Science, 255, pp.1707~1710 (1992)
28. Reynolds BA, "A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes", J Neurosci, 12, pp.4565~4574 (1992)
29. Galli R, "Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma", Cancer Res, 64, pp.7011~7021 (2004)
30. Singh SK, "Cancer stem cells in nervous system tumors", Oncogene, 23, pp.7267~7273 (2004)
31. Laks DR, "Neurosphere formation is an independent predictor of clinical outcome in malignant glioma", Stem Cells, 27, pp.980~987 (2009)
32. Pallini R, "Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme", Clin Cancer Res, 14, pp.8205~8212 (2008)
33. Rickman DS, "Distinctive molecular profiles of high-grade and lowgrade gliomas based on oligonucleotide microarray analysis", Cancer Res, 61, pp.6885~6891 (2001)
34. Phillips HS, "Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis", Cancer Cell, 9, pp.157~173 (2006)
35. Günther HS, "Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria", Oncogene, 27, pp.2897~2909 (2008)
36. Tso CL, "Distinct transcription profiles of primary and secondary glioblastoma subgroups", Cancer Res, 66, pp.159~167 (2006)
37. Nakano I, "Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells", J Neurosci Res, 86, pp.48~60 (2008)
38. Horvath S, "Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target" (2006), Proc Natl Acad Sci U S A 2006. In press.
39. Ivanova NB, "A stem cell molecular signature", Science, 298, pp.601~604 (2002)
40. Taipale J, "The Hedgehog and Wnt signalling pathways in cancer", Nature, 411, pp.349~354 (2001)
41. Wechsler-Reya R, "The developmental biology of brain tumors", Annu Rev Neurosci, 24, pp.385~428 (2001)
42. Li Z, "Turning cancer stem cells inside out: an exploration of glioma stem cell signaling pathways", J Biol Chem, 284, pp.16705~16709 (2009)
43. Nakano I, "Maternal embryonic leucine zipper kinase (MELK) regulates multipotent neural progenitor proliferation", J Cell Biol, 170, pp.413~427 (2005)
44. Choe G, "Analysis of the phosphatidylinositol 3’-kinase signaling pathway in glioblastoma patients in vivo", Cancer Res, 63, pp.2742~2746 (2003)
45. Vivanco I, "The phosphatidylinositol 3-Kinase AKT pathway in human cancer", Nat Rev Cancer, 2, pp.489~501 (2002)
46. Wang G, "Increased expression of Akt2 and activity of PI3K and cell proliferation with the ascending of tumor grade of human gliomas", Clin Neurol Neurosurg, 112, pp.324~327 (2010)
47. Maira SM, "PI3K inhibitors for cancer treatment: where do we stand?", Biochem Soc Trans, 37, pp.265~272 (2009)
48. Brown EJ, "A mammalian protein targeted by G1-arresting rapamycin-receptor complex", Nature, 369, pp.756~758 (1994)
49. Bjornsti MA, "The TOR pathway: a target for cancer therapy", Nat Rev Cancer, 4, pp.335~348 (2004)
50. Chiu MI, "RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12", rapamycin complex, 1994, pp.91, 12574~12578
51. Sabatini DM, "RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs", Cell, 78, pp.35~43 (1994)
52. O’Reilly KE, "mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt", Cancer Res, 66, pp.1500~1508 (2006)
53. Cloughesy TF, "Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma", PLoS Med, 5, pp.e8~ (2008)
54. Hosoi H, "Studies on the mechanism of resistance to rapamycin in human cancer cells", Mol Pharmacol, 54, pp.815~824 (1998)
55. Efeyan A, "mTOR and cancer: many loops in one pathway", Curr Opin Cell Biol, 22, pp.169~176 (2010)
56. Carracedo A, "Deconstructing feedbacksignaling networks to improve anticancer therapy with mTORC1 inhibitors", Cell Cycle, 7, pp.3805~3809 (2008)
57. Thoreen CC, "An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1", J Biol Chem, 284, pp.8023~8032 (2009)
58. Thoreen CC, "Rapamycin inhibits mTORC1, but not completely", Autophagy, 5, pp.725~726 (2009)
59. Gaiano N, "The role of notch in promoting glial and neural stem cell fates", Annu Rev Neurosci, 25, pp.471~490 (2002)
60. Purow BW, "Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation", Cancer Res, 65, pp.2353~2363 (2005)
61. Solecki DJ, "Activated Notch2 signaling inhibits differentiation of cerebellar granule neuron precursors by maintaining proliferation", Neuron, 31, pp.557~568 (2001)
62. Androutsellis-Theotokis A, "Notch signalling regulates stem cell numbers in vitro and in vivo", Nature, 442, pp.823~826 (2006)
63. Pierfelice TJ, "Notch, neural stem cells, and brain tumors", Cold Spring Harb Symp Quant Biol, 73, pp.367~375 (2008)
64. Stommel JM, "Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies", Science, 318, pp.287~290 (2007)
65. Mischel PS, "Targeted molecular therapy of GBM", Brain Pathol, 13, pp.52~61 (2003)
66. Mungamuri SK, "Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53", Cancer Res, 66, pp.4715~4724 (2006)
67. Chan SM, "Notch signals positively regulate activity of the mTOR pathway in Tcell acute lymphoblastic leukemia", Blood, 110, pp.278~286 (2007)
68. Perumalsamy LR, "A hierarchical cascade activated by non-canonical Notch signaling and the mTOR-Rictor complex regulates neglect-induced death in mammalian cells", Cell Death Differ, 16, pp.879~889 (2009)
69. Ma J, "Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3", p63, Notch cascade, pp.J Clin Invest, 2010[DOI]
70. Wang Z, "Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways", J Cell Biochem, 109, pp.726~736 (2010)
71. Kitano H, "A robustness-based approach to systems-oriented drug design", Nat Rev Drug Discov, 6, pp.202~210 (2007)
72. Hambardzumyan D, "Cancer stem cells and survival pathways", Cell Cycle, 7, pp.1371~1378 (2008)
73. Johannessen TC, "DNA repair and cancer stem-like cells--potential partners in glioma drug resistance?", Cancer Treat Rev, 34, pp.558~567 (2008)
74. Lu C, "Chemoresistance in gliomas", Mol Cell Biochem, 312, pp.71~80 (2008)
75. Dean M, "Tumour stem cells and drug resistance", Nat Rev Cancer, 5, pp.275~284 (2005)
76. Hirschmann-Jax C, "A distinct “side population” of cells with high drug efflux capacity in human tumor cells", Proc Natl Acad Sci U S A, 101, pp.14228~14233 (2004)
77. Nowell PC, "The clonal evolution of tumor cell populations", Science, 194, pp.23~28 (1976)
78. Miller DG, "On the nature of susceptibility to cancer. The presidential address", Cancer, 46, pp.1307~1318 (1980)
79. Loeb LA, "A mutator phenotype in cancer", Cancer Res, 61, pp.3230~3239 (2001)
80. Mullighan CG, "Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia", Science, 322, pp.1377~1380 (2008)
81. Shah SP, "Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution", Nature, 461, pp.809~813 (2009)
82. Shackleton M, "Heterogeneity in cancer: cancer stem cells versus clonal evolution", Cell, 138, pp.822~829 (2009)
83. Shapiro JR, "Isolation, karyotype, and clonal growth of heterogeneous subpopulations of human malignant gliomas", Cancer Res, 41, pp.2349~2359 (1981)
84. Yung WK, "Heterogeneous chemosensitivities of subpopulations of human glioma cells in culture", Cancer Res, 42, pp.992~998 (1982)
85. Piccirillo SG, "Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells", Nature, 444, pp.761~765 (2006)
86. Rehen SK, "Chromosomal variation in neurons of the developing and adult mammalian nervous system", Proc Natl Acad Sci U S A, 98, pp.13361~13366 (2001)
87. Westra JW, "Aneuploid mosaicism in the developing and adult cerebellar cortex", J Comp Neurol, 507, pp.1944~1951 (2008)
88. Sareen D, "Chromosome 7 and 19 trisomy in cultured human neural progenitor cells", PLoS One, 4, pp.e7630~ (2009)
89. Schwab ED, "Cancer as a complex adaptive system", Med Hypotheses, 47, pp.235~241 (1996)
90. Kitano H, "Cancer as a robust system: implications for anticancer therapy", Nat Rev Cancer, 4, pp.227~235 (2004)
91. Heppner GH, "Tumor heterogeneity", Cancer Res, 44, pp.2259~2265 (1984)
92. Axelrod R, "Evolution of cooperation among tumor cells", Proc Natl Acad Sci U S A, 103, pp.13474~13479 (2006)
93. Grizzi F, "The complexity of anatomical systems", Theor Biol Med Model, 2, pp.26~ (2005)
94. Grizzi F, "Cancer: looking for simplicity and finding complexity", Cancer Cell Int, 6, pp.4~ (2006)
95. Ashby W, "Requisite variety and its implications for the control of complex systems", Cybernetica, 1, pp.83~89 (1958)
96. Gilbertson RJ, "Making a tumour’s bed: glioblastoma stem cells and the vascular niche", Nat Rev Cancer, 7, pp.733~736 (2007)
97. Hoelzinger DB, "Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment", J Natl Cancer Inst, 99, pp.1583~1593 (2007)
98. Calabrese C, "A perivascular niche for brain tumor stem cells", Cancer Cell, 11, pp.69~82 (2007)
99. Wu M, "Interaction between Ras(V12) and scribbled clones induces tumour growth and invasion", Nature, 463, pp.545~548 (2010)

관련 논문AI추천